Study of a new drug for advanced head and neck and other solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug, SI-B036, for people with advanced head and neck tumors or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and slow the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have been diagnosed with a solid tumor (like head and neck cancer) that is locally advanced or has spread to other parts of the body.
- You are physically able to care for yourself (ECOG 0 or 1).
- You have a tumor that can be measured on scans.
- You are willing to provide a tumor tissue sample (from a previous biopsy or a new one).
- You have recovered from side effects of prior treatments and have adequate organ function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called SI-B036 for people with advanced gynecological cancers or other solid tumors that have spread. The goal is to see if the drug is safe and how well it might work.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
This trial tests an experimental drug called IBI3020 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for these patients.
This trial tests a new drug (SI-B036) for people with advanced urological tumors or other solid tumors that have spread. The goal is to see if the drug is safe and effective, and it might help shrink tumors or slow their growth.
This early-stage trial tests a new drug called SI-B036 in patients with advanced cancers that have spread or cannot be completely removed by surgery. The goal is to understand how safe the drug is and how well it works.
Hear when a new Head and Neck Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.